Is there a rule for DCB in ACS setting?

Session comprising selected EuroPCR 2026 abstract submissions

Moderators: R. Waksman, D. Arroyo

Speakers: H. Hasegawa, P. Serruys, I. Jurin, H. Cubero-Gallego, N. Pyrpyris, S. Basavarajaiah

Summary

This session examines the application of drug-coated balloons (DCB) in the acute coronary syndrome (ACS) setting, comparing outcomes with drug-eluting stents (DES). It discusses the impact of intraluminal thrombus, real-world registry data on DCB-first strategies in STEMI, and multicentre experiences with DCB use in STEMI and coronary calcification.

Presentations available when logged in:

Impact of intraluminal thrombus on angiographic outcomes after DCB angioplasty
Stent-free PCI in ACS: real-world outcomes of a DCB-first strategy
Use of DEB in STEMI and coronary calcification: results from a multicentre registry
DCB vs. DES angioplasty in patients presenting with STEMI
DCB in STEMI; multicentre international registry

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Is there a rule for DCB in ACS setting?

Session comprising selected EuroPCR 2026 abstract submissions

Log in or create account for free